Floatz logo

Campath

Lymphoma, AIDS-related

National Cancer Institute (NCI)Phase 2Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
39/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Lymphoma, AIDS-related cohort.

Asset / SponsorPhaseRating
Tabelecleucel
D

Same molecule, other indications

Campath is also rated in:

sickle cell diseaseDormant
BB
Indicative ·
65 / 100
View asset →
plasma cell myelomaDormant
B
Indicative ·
62 / 100
View asset →
B-cell chronic lymphocytic leukemiaDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →